Literature DB >> 19958609

In vivo effects of citric acid/zwitterionic surfactant cleansing solution on rabbit sinus mucosa.

Edwin Tamashiro1, Caroline A Banks, Bei Chen, David A Gudis, Laurel Dogrhamji, Matthew Myntti, Jennifer Medina, Alexander G Chiu, Noam A Cohen.   

Abstract

BACKGROUND: Chronic rhinosinusitis that is refractory to medical or surgical intervention may involve a particularly resistant form of infection known as a bacterial biofilm that is recalcitrant to antibiotics secondary to physical barrier characteristics. Recently, a novel sinus cleansing solution, citric acid/zwitterionic surfactant (CAZS) was shown to be extremely effective in disrupting biofilms in vitro. The purpose of this study was to determine the effects of CAZS on sinonasal epithelium In vivo compared with normal saline.
METHODS: Indwelling catheters were placed into the right maxillary sinus of New Zealand white rabbits. CAZS solution or normal saline (10 mL) was instilled at a rate of 20 mL/minute into the sinus followed by aspiration. Rabbits were killed 1, 3, and 6 days after treatment. Mucosa from both maxillary sinuses was harvested and evaluated for physiological activity (ciliary beating) as well as morphological integrity of the epithelium by scanning electron microscopy.
RESULTS: One day after treatment, beating cilia was evident with morphological analysis shown intact epithelium with 80-85% denudation of cilia compared with saline. Three days after treatment, ciliary activity was again noted with morphological evidence of persistent denuded cilia. By day 6 after treatment, the epithelium had regenerated cilia over the apical surface. Throughout the recovery period beating cilia was evident in CAZS-treated sinuses.
CONCLUSION: This study shows that although CAZS acutely denudes respiratory cilia, the remaining cilia are active. Additionally, the epithelial barrier appears intact with active ciliogenesis, and reciliation of the mucosal surface occurring 6 days after treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19958609     DOI: 10.2500/ajra.2009.23.3398

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  7 in total

1.  Topical Drug Delivery for Chronic Rhinosinusitis.

Authors:  Jonathan Liang; Andrew P Lane
Journal:  Curr Otorhinolaryngol Rep       Date:  2012-12-27

Review 2.  Surfactants in the management of rhinopathologies.

Authors:  Philip L Rosen; James N Palmer; Bert W O'Malley; Noam A Cohen
Journal:  Am J Rhinol Allergy       Date:  2013 May-Jun       Impact factor: 2.467

3.  The role of topical therapies in the treatment of chronic rhinosinusitis.

Authors:  Jeffrey D Suh; Vijay Ramakrishnan; Alexander G Chiu
Journal:  Braz J Otorhinolaryngol       Date:  2011 Nov-Dec

4.  Innate immunity and chronic rhinosinusitis: What we have learned from animal models.

Authors:  Nyall R London; Andrew P Lane
Journal:  Laryngoscope Investig Otolaryngol       Date:  2016-06-10

5.  Evaluation of sheep sinonasal endoscopic anatomy as a model for rhinologic research.

Authors:  Luis Macias-Valle; Andres Finkelstein-Kulka; Jamil Manji; Christopher Okpaleke; Salahuddin Al-Salihi; Amin R Javer
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2018-05-25

Review 6.  Current Perspective on Nasal Delivery Systems for Chronic Rhinosinusitis.

Authors:  Junhu Tai; Kijeong Lee; Tae Hoon Kim
Journal:  Pharmaceutics       Date:  2021-02-10       Impact factor: 6.321

Review 7.  Biofilms in chronic rhinosinusitis: Pathophysiology and therapeutic strategies.

Authors:  Judd H Fastenberg; Wayne D Hsueh; Ali Mustafa; Nadeem A Akbar; Waleed M Abuzeid
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2016-05-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.